Probing the DNA Reactivity and the Anticancer Properties of a Novel Tubercidin-Pt(II) Complex
Stefano D'Errico1, Andrea Patrizia Falanga2, Domenica Capasso1
1CESTEV, University of Naples Federico II, via Tommaso De Amicis, 95, 80145 Napoli, Italy.
Abstract:
Herein, we reported on the synthesis of a novel Pt(II) neutral complex having as ligand the nucleoside tubercidin, a potent anti-tumor agent extracted from the bacterium Streptomyces Tubercidicus. In detail, the chelation of the metal by a diamine linker installed at C6 purine position of tubercidin assured the introduction of a cisplatin-like unit in the molecular scaffold. The behavior of the synthesized complex with a double-strand DNA model was monitored by CD spectroscopy and compared with that of cisplatin and tubercidin. In addition, the cell viability was evaluated against HeLa, A375 and WM266 human cancer cell lines using the MTT test. Lastly, the results of the apoptotic assay (FITC Annexin V) performed on the HeLa cancer cell line are also reported.
More Related Videos
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Related Concept Videos
Mutagenicity and Carcinogenicity
Other Unique Bacteria
Drugs that Destabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against...
